Du patient à l'objet de science
Le management du risque en pharmacovigilance, point de vue de la théorie néo-institutionnelle
Congrès de l'AIM, May 2018, MONTREAL, Canada
HegelVol.8 N°1 - 2018
Yannick Bardie, Thérèse Libourel.
5. Information Systems for Supporting Strategic Decisions and Alerts in Pharmacovigilance
INTELLIGENCE IN LIFE'S PUBLICATIONS
This collection was initiated during the monthly meetings of Intelligence in Life. The aim of the contributors was to provide professionals, institutions and associations with research of high scientific value from a wide range of expertise. Eventually, this document base will be a multidisciplinary editorial base for drawing up new reflections, Proposals and strategies for a more inclusive approach to health-related specificities and clinical trials in an ecosystem with unclear contours and interactions between actors difficult to evaluate.